Our allelotype analysis identifies a CRD between 17p11.2 and 17p telomere, which encompasses the TP53 locus, as the major genetic alteration in the low-grade astrocytomas. This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).